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Extracorporeal shock wave lithotripsy (ESWL) is an
effective, well-established method to treat ureteral
stones and has become the standard therapy for most
upper urinary tract stones because of its low morbid-
ity and acceptable success rate [1]. Many studies have
demonstrated that stone consistency, size, shape, loca-
tion, attenuation value on computed tomography,
and body mass index (BMI) are predictors of treat-
ment outcome after ESWL, as determined by the
stone-free rate [2–5].
Ureteral obstruction not only decreases renal
function but also decreases ureteral peristalsis and
pressure, which affects ureteral stone migration [6].
Received: Aug 6, 2008 Accepted: Nov 3, 2008
Address correspondence and reprint requests to:
Dr Chia-Chu Liu, Department of Urology,
Kaohsiung Medical University Hospital, Tzyou
1st Road, Kaohsiung 807, Taiwan.
E-mail: m8201055@yahoo.com.tw
IMPACT OF HYDRONEPHROSIS ON TREATMENT
OUTCOME OF SOLITARY PROXIMAL URETERAL
STONE AFTER EXTRACORPOREAL SHOCK
WAVE LITHOTRIPSY
Hsi-Lin Hsiao,1 Shu-Pin Huang,2,3 Wen-Jeng Wu,2,3 Yung-Chin Lee,2 Wei-Ming Li,2 Yii-Her Chou,2,3
Ai-Wen Chang,2 Chun-Hsiung Huang,2,3 Shu-Chin Sun,4 and Chia-Chu Liu2
1Department of Urology, Kaohsiung Municipal Min-Sheng Hospital, 2Department of Urology, Kaohsiung
Medical University Hospital, 3Department of Urology, College of Medicine, Kaohsiung Medical University,
and 4Department of Anesthesiology, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung, Taiwan.
The purpose of this study was to investigate the impact of hydronephrosis on the treatment 
outcome of patients with a solitary proximal ureteral stone after extracorporeal shock wave
lithotripsy (ESWL). A total of 182 consecutive patients who underwent ESWL for a solitary prox-
imal ureteral stone of between 5 and 20 mm in size in our institution were included in this study.
The degree of hydronephrosis was defined by renal ultrasonography. Patient data, stone size,
shock wave numbers and shock wave energy were also recorded. Treatment outcome was evalu-
ated 3 months after the first session of ESWL. In multivariate analysis, only the maximal stone
length (odds ratio [OR], 0.15; 95% confidence interval [CI], 0.03–0.91; p = 0.04) and the degree of
hydronephrosis (OR, 0.40; 95% CI, 0.16–0.98; p = 0.045) were significant predicting factors for
stone-free status 3 months after ESWL. For stones ≤ 10 mm, the stone-free rate decreased from
80% in patients with mild hydronephrosis to 56.4% in those with moderate to severe hydro-
nephrosis. For stones > 10 mm, the stone-free rate decreased further, from 65.2% in patients with
mild hydronephrosis to 33.3% in those with moderate to severe hydronephrosis. In summary,
patients with a solitary proximal ureteral stone and a stone > 10 mm, the treatment outcome after
ESWL was not good if moderate to severe hydronephrosis was noted on ultrasonography.
Alternative treatments, such as ureteroscopic lithotripsy, may be appropriate as initial treatment
or after failure of one session of ESWL.
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Whether hydronephrosis affects the outcome of ESWL
treatment remains controversial. Some authors have
reported that stone-induced urinary obstruction re-
duced the success rate of ESWL in treating ureteral
stones [7,8], but others did not [9–12]. Thus, we per-
formed a retrospective study to investigate whether
the presence and degree of stone-induced hydro-
nephrosis affects the treatment outcome of ESWL in
patients with solitary proximal ureteral stones.
METHODS
From January 2004 to May 2006, 182 consecutive
patients who underwent ESWL for solitary proximal
ureteral stones from 5 to 20 mm in size in our 
institution were included in this study by retrospec-
tive chart review. All subjects provided informed
consent before enrolment into the study. Exclusion
criteria were prior stone manipulation, ureteral stric-
tures, congenital anomalies causing hydronephrosis,
pregnancy, coagulopathies, and renal insufficiency
with serum creatinine > 2.0 mg/dL. Patients who re-
ceived auxiliary procedures, such as percutaneous
nephrostomy/double-J catheter insertion or endo-
scopic treatment during the follow-up period were
also excluded.
Pre-ESWL radiographic investigations included
radiographs of the kidney, ureter and bladder (KUB),
and ultrasonography. Intravenous urography or ret-
rograde pyelography was done if KUB examination
and ultrasonography were uncertain. In all patients,
radio-opaque stones were confirmed in pre-ESWL
radiographic assessment and were located between
the ureteropelvic junction and the pelvic brim. Stone
size was measured as the maximal stone length on
KUB. The degree of hydronephrosis was defined by
ultrasonography, as previously described by Pearle
et al [3]. In brief, in severe disease, there was a sac-
like collecting system and markedly thin parenchyma;
in moderate disease, the calices ballooned outward
and the papillae were barely visible; and in mild dis-
ease, there was subtle distension of the fornices to
frank distension of the calices, but the papillae were
still easily identified. Two urologic specialists assessed
all imaging studies and, if the results were not consis-
tent, a third urologic specialist also evaluated them.
Laboratory investigations included urinalysis, serum
creatinine determination and a coagulation profile.
Patient data including age, gender, weight and height
were collected. The BMI was calculated for each
patient by dividing weight in kilograms by height in
meters squared.
Stones were fragmented with the patient in the
supine position and under radiographic guidance with
a Siemens Lithostar multiline lithotripter (Erlangen,
Germany). The number of shock waves delivered
and energy (in kilovolts) used in each ESWL treat-
ment were recorded. The post-ESWL radiographic
evaluation included KUB and ultrasonography every
4–6 weeks for at least 3 months to assess the effec-
tiveness of the treatment. Patients in whom ESWL
failed to completely disintegrate the stone underwent
another treatment 1 month after the first ESWL ses-
sion. The end point of the study was 3 months after
the first session of ESWL. The stone-free (SF) group
of patients had radiographic evidence of complete
disappearance of the stone or an insignificant resid-
ual stone (≤ 3 mm). The residual-stones (RS) group
comprised patients with residual stones > 3 mm.
Results are expressed as mean± standard deviation
(SD), unless otherwise indicated. Quantitative vari-
ables in the different groups were compared using
Student’s t test, and qualitative variables were com-
pared by the contingency table χ2 test. Logistic regres-
sion was used to test the associations between outcome
status and different predicting factors after adjusting
for other covariates. SPSS version 12 (SPSS Inc.,
Chicago, IL, USA) was used for statistical analyses. 
A two-sided p value <0.05 was considered statistically
significant.
RESULTS
Of the 182 patients, 162 completed 3 months of 
follow-up and were analyzed. One hundred and three
patients were in the SF group, and the other 59
patients were in the RS group. The overall stone-free
rate was 63.6%. Table 1 shows the patient and clinical
characteristics of each patient group. The RS group
had significantly larger stones (p < 0.001) and a higher
degree of hydronephrosis (p<0.001) than the SF group.
No statistically significant differences were found
between the two groups with respect to age, BMI,
side where the stone was located (left or right), urine
specific gravity, urinary pH, shock wave numbers
and shock wave energy.
In multivariate analysis (Table 2), maximal stone
length (odds ratio [OR], 0.15; 95% confidence interval
[CI], 0.03–0.91; p = 0.04) and the degree of hydro-
nephrosis (OR, 0.40; 95% CI, 0.16–0.98; p = 0.045) were
still significant predicting factors for stone-free status
3 months after ESWL.
We further evaluated the treatment outcome for
patients with different stone sizes (stone size ≤10 mm,
and stone size > 10 mm). The overall stone-free rate
was 71.6% in the patients with stones ≤ 10 mm and
47.2% in those with stones > 10 mm. The degree of
hydronephrosis was still a significant predicting fac-
tor for the treatment outcome in stones of different
sizes (Table 3). In the group with stones ≤ 10 mm, the
stone-free rate decreased from 80% in patients with
mild hydronephrosis to 56.4% in those with moderate
to severe hydronephrosis. For the group with stones
> 10 mm, the stone-free rate decreased further, from
65.2% to 33.3%. The impact of hydronephrosis seemed
to become more apparent for stones > 10 mm (OR,
0.267; 95% CI, 0.085–0.839; p = 0.024) than for stones
≤ 10 mm (OR, 0.324; 95% CI, 0.137–0.766; p = 0.01).
DISCUSSION
The natural history of ureteral stones favors sponta-
neous elimination, and the incidence depends on 
the size of the stones. The incidence of spontaneous
elimination varies from 60% to 98% for stones with a
diameter ≤ 5 mm, and decreases rapidly beyond that
size [13–17]. Spontaneous elimination becomes rare if
the diameter exceeds 6 mm [13–17]. In addition, the
spontaneous passage rate of stones is also highly
dependent on the stone location. The overall passage
rate from the proximal ureter was only 22% in one
study [18].
ESWL for proximal ureteral stones
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Table 1. Patient characteristics and extracorporeal shock wave lithotripsy parameters of the stone-free and residual 
stone groups*
Characteristic Stone-free Residual stones p
Patients 103 59
Male/female 63/40 49/10
Stone side, right/left 36/67 25/34 0.41
Age (yr) 47.2 ± 12.2 49.7 ± 13.4 0.23
Body mass index (kg/m2) 25.0 ± 3.4 25.7 ± 4.1 0.38
Urine pH 6.27 ± 0.79 6.43 ± 0.56 0.22
Urine specific gravity 1.015 ± 0.006 1.017 ± 0.010 0.29
Maximal stone length (mm) 8.0 ± 2.4 10.7 ± 4.2 < 0.001
Shock wave number 3,391 ± 199 3,427 ± 202 0.27
Energy level (kV) 15.2 ± 0.6 15.4 ± 0.7 0.29
Degree of hydronephrosis < 0.001
Mild 71 (68.9) 22 (37.3)
Moderate 30 (29.1) 21 (35.6)
Severe 2 (2.0) 16 (27.1)
*Data presented as n or mean ± standard deviation or n (%).
Table 2. Multivariate analysis of predicting factors for
stone-free rate at 3 months after extracorporeal shock
wave lithotripsy
Odds ratio 95% CI p
Age 1 0.95–1.05 0.934
Sex 3.75 0.96–14.5 0.056
Stone side 0.55 0.15–2.03 0.37
Body mass index 0.85 0.72–1.01 0.059
Urine pH 0.8 0.30–2.11 0.649
Urine specific 0.76 0.29–1.96 0.604
gravity
Maximal stone 0.15 0.03–0.91 0.04
length 
Shock wave 1 0.99–1.002 0.201
number
Energy level 1.27 0.48–3.36 0.624
Degree of 0.4 0.16–0.98 0.045
hydronephrosis
CI = confidence interval.
The treatment options for ureteral stones include
ESWL, ureteroscopic lithotripsy, open ureterolitho-
tomy, percutaneous ureterolithotomy and laparoscopic
or retroperitoneal ureterolithotomy [19]. Most physi-
cians favor a low-invasive therapeutic approach such
as ESWL and ureteroscopic lithotripsy as the first-
line treatment for patients with ureteral stones. The
“end of the stone age” was announced after the intro-
duction of ESWL in the early 1980s [20]. For proximal
ureteral stones, several studies have shown that the
treatment outcomes of ESWL and ureteroscopic litho-
tripsy are comparable [21]. Because ESWL is less
invasive, has a lower risk of complications than sur-
gery, and can be performed with only analgesics and
sedation, most guidelines recommend it as the first-
line treatment for proximal ureteral stones [22].
Urinary obstruction is a serious problem as it can
lead to progressive kidney dysfunction and several
severe complications. Ureteral obstruction produces
not only a progressive decrease in renal excretory
function but also a fairly rapid change in ureteral
peristaltic function [6]. Decreased ureteral peristalsis
and pressure caused by ureteral obstruction may af-
fect ureteral stone migration [6]. However, the rela-
tionship between stone-induced urinary obstruction
and treatment outcome after ESWL in patients with
ureteral stones is still a matter of debate. Delakas 
et al showed that the likelihood of ESWL treatment
failure increases with the severity of urinary obstruc-
tion [8]. Kageyama et al reported that moderate to
severe hydronephrosis and stone location in the mid-
dle and lower ureters were two independent risk 
factors for poor treatment outcome after ESWL [7]. 
In contrast, Kirkali et al reported that urinary obstruc-
tion did not affect the success rate of ESWL in terms
of stone disintegration or passage [9]. Similarly, Singh
et al reported that the degree of obstruction did not
affect clearance rates for proximal ureteral stones
treated with ESWL [11].
In our study, the degree of hydronephrosis and
maximal stone length were two independent predict-
ing factors for the treatment outcome of solitary
proximal ureteral stones after ESWL. In addition, the
impact of hydronephrosis on the treatment outcome
was more obvious in those with stones > 10 mm than
those with stones ≤ 10 mm.
A meta-analysis reported by the American
Urological Association (AUA) revealed that the best
stone clearance rates for ESWL in those with stones
≤ 10 mm was 87% compared with 76% for those with
stones sized 11–20 mm [1]. Pace et al also reported a
significantly better response to shock wave applica-
tion in proximal and middle ureteral stones than
those in the distal ureter [23]. In our study, the stone-
free rate of solitary proximal ureteral stones 3 months
after ESWL was also correlated with maximal stone
length. The overall stone-free rate was 71.6% in those
with stones ≤ 10 mm and 47.6% in those with stones
between 11 mm and 20 mm.
In one recent study, the stone-free rate after ESWL
for proximal ureteral stones was better than that for
middle and distal ureteral stones (80.6%, 75.8% and
76.7%, respectively) [24]. Shiroyanagi et al also re-
ported that the overall success rates at 3 months after
ESWL were 82.6%, 78.6% and 63.8% for proximal,
middle and distal ureteral stones, respectively [25].
Our overall success rate for solitary proximal ureteral
stones 3 months after ESWL was 63.58%, which was
lower than in previous studies [24,25]. In our study,
20 patients were lost to follow-up after ESWL treat-
ment and were excluded from the final analysis. The
reasons why these patients were lost to follow-up may
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Table 3. Effect of hydronephrosis on stone-free rate for different stone sizes after extracorporeal shock wave
lithotripsy*
Stone-free (%) Residual stones (%) OR (95% CI)
Stone size ≤ 10 mm 78 (71.6) 31 (28.4)
Degree of hydronephrosis
Mild 56 (80.0) 14 (20.0) 1.00 (Ref)
Moderate + severe 22 (56.4) 17 (43.6) 0.324 (0.137–0.766)
Stone size > 10 mm 25 (47.2) 28 (52.8)
Degree of hydronephrosis
Mild 15 (65.2) 8 (34.8) 1.00 (Ref)
Moderate + severe 10 (33.3) 20 (66.6) 0.267 (0.085–0.839)
*Data presented as n (%). OR = odds ratio; CI = confidence interval; Ref = reference category.
be due to elimination of stones or symptoms after one
session of ESWL therapy, so the overall success rate
may be underestimated. Another possible reason is
that the National Health Insurance in Taiwan only
covers five ESWL procedures per year. Therefore,
only 16 patients received two sessions of ESWL in 
3 months and none received three or more sessions 
in this study. The lithotriptor used in this study may
be another reason for the low stone-free rate. An HM3
lithotriptor has reported success rates ranging from
68% to 97% for proximal ureteral stones of all sizes
[26–28]. We used a Siemens Lithostar multiline litho-
tripter, which does not have the same success rate.
Stone manipulation before ESWL has been discussed
in several studies [29,30]. Because impaired renal func-
tion may decrease the stone–fluid interface and uri-
nary obstruction seems to affect stone migration, an
interventional procedure with urinary drainage
(either nephrostomy tube or ureteral stent) is usually
recommended for those with renal deterioration [31].
Insertion of a double pigtail stent alongside the ure-
teral stone enhanced fragmentation because of an in-
creased stone–fluid interface. Although Chaussy and
Schmiedt reported a 95% success rate for in situ ESWL
[32], other centers failed to reach a similar outcome
and have recommended pre-ESWL stone manipula-
tion to improve results [33,34]. Our study excluded
patients who received auxiliary procedures, such as
percutaneous nephrostomy/double-J-catheter inser-
tion before ESWL treatment, and this may be partly
responsible for the low overall success rate in our
study.
In our study, only the degree of hydronephrosis
and maximal stone length were independent pre-
dictive factors for the treatment outcome of solitary
proximal ureteral stones after ESWL. In addition, the
degree of hydronephrosis affected the treatment out-
come for stones of different sizes, and the impact was
more apparent in patients with stones > 10 mm than
in those with stones ≤ 10 mm. In patients with a soli-
tary proximal ureteral stone > 10 mm, the treatment
outcome by ESWL was not good if moderate to severe
hydronephrosis was noted on ultrasonography, so an
alternative treatment such as ureteroscopic lithotripsy
may be appropriate as initial treatment or after treat-
ment failure of one session of ESWL. Further studies
with large sample sizes and the use of different
lithotriptors are needed to verify our preliminary
results.
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病人癒後之影響。總共 182 位結石大小位於 5 至 20 毫米之間的近端輸尿管單一顆結
石的病患在本科接受過體外震波碎石術納入本次的研究。以超音波來定義腎積水的程
度。病患人數、結石大小、震波數目及能源也都詳細記錄。在接受過碎石術之後 3 個
月來評估治療的癒後。在多變項分析下，只有結石的最大長度 (OR 0.15，95% CI 
0.03–0.91，p = 0.04) 及腎積水的程度 (OR 0.40，95% CI 0.16–0.98，p = 0.045) 
可當作以體外震波碎石術治療 3 個月之後的結石清除率的預測因子。如果結石的長度
小於或等於 10 毫米的輕度腎積水的病患，結石清除率可達到 80%，不過如果腎積水
為中度至重度的病患，清除率只能達到 56.4%。如果結石的長度超過 10 毫米的族群
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